Smoking cessation support for people living with HIV in Botswana
Botswana Smoking Abstinence Reinforcement Trial (BSMART)
['FUNDING_U01'] · UNIVERSITY OF MARYLAND BALTIMORE · NIH-11180409
This project offers brief counseling, referrals, and clinic-based support to help people with HIV in Botswana stop smoking.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MARYLAND BALTIMORE (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-11180409 on ClinicalTrials.gov |
What this research studies
If you take part, clinic staff and trained lay health workers will add a short smoking screen, counseling, and referral steps (SBIRT) into your regular HIV care. You will be offered counseling, possible referral to cessation services, and regular follow-up visits to track progress. The project simultaneously measures how well the program helps people quit and studies the best ways to put the program into routine HIV clinics across Botswana. Quit status may be checked during follow-up visits and with biochemical tests to confirm abstinence.
Who could benefit from this research
Good fit: Adults living with HIV who currently smoke and receive care at participating HIV clinics in Botswana are the ideal candidates.
Not a fit: People who do not smoke, who are not treated at participating clinics, or who are unwilling to engage with counseling or follow-up are unlikely to benefit from this project.
Why it matters
Potential benefit: If successful, it could help people with HIV quit smoking and lower their risk of lung cancer and other smoking-related illnesses.
How similar studies have performed: SBIRT and clinic-based smoking cessation programs have helped smokers quit in many settings, but their effectiveness and practical rollout in HIV clinics in southern Africa are less tested.
Where this research is happening
BALTIMORE, UNITED STATES
- UNIVERSITY OF MARYLAND BALTIMORE — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHARURAT, MANHATTAN E — UNIVERSITY OF MARYLAND BALTIMORE
- Study coordinator: CHARURAT, MANHATTAN E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus